STEVE CHAUSSY - 30 Mar 2022 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Financial Officer
Signature
/s/ Kenneth L. Londoner, attorney-in-fact
Issuer symbol
BSGM
Transactions as of
30 Mar 2022
Net transactions value
$0
Form type
4
Filing time
08 Apr 2022, 18:24:24 UTC
Previous filing
24 May 2021
Next filing
24 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSGM Restricted Stock Award $0 +200,000 $0.000000 200,000 30 Mar 2022 Common Stock 200,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of restricted stock shall be fully vested as of March 30, 2022, the date of the grant.